About Careers MedBlog Contact us
Medindia LOGIN REGISTER
Advertisement

Pfizer's Best-selling Cholesterol Drug Lipitor Open for Generic Competition

by Thilaka Ravi on December 1, 2011 at 1:11 PM
Font : A-A+

Pfizer's Best-selling Cholesterol Drug Lipitor Open for Generic Competition

Pfizer's patent on the best-selling cholesterol-lowering drug of all-time, Lipitor, expired on Wednesday, opening the market for generic competitors for America's most popular medication.

Lipitor came on the market in 1997, and has raked in some $100 billion for Pfizer even in a crowded market that includes various other cholesterol-lowering statins, many of which have already gone generic.

Advertisement

In the United States, anti-cholesterol drugs account for 255 million prescriptions a year, and about nine million people are taking Lipitor.

US-based Watson Pharmaceuticals immediately announced its launch of a generic version of Lipitor, atorvastatin calcium, under an exclusive supply and distribution agreement with Pfizer, whereby Pfizer manufactures the drug and Watson sells it, sharing net sales with Pfizer until 2016.
Advertisement

Indian-based Ranbaxy, which was also expected to release its generic in the next six months, still awaits the green light from US authorities due to delays over problems with quality control and some of their Indian factories.

"There should be a price war in that first six months," said Morningstar analyst Damien Conover.

As companies elbow for market share of the cheaper generic version of Lipitor, Pfizer is left hunting for new sources of revenue to replace the cash flow from its longtime star, which made up 15 percent of Pfizer's annual sales.

Pfizer has not released its projected losses due to the patent expiration, but its company forecasts call for sales in 2012 of $63-63.5 billion , versus $67.8 billion in 2010.

Lipitor global sales were over $10 billion last year. Conover estimated a sales figure of $3.8 billion in 2012.

Source: AFP
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
What's New on Medindia
Macronutrients Calculator for Weight Loss
Quiz on Kidney
World Disability Day 2022 - The Role of Innovative Transformation
View all
Recommended Reading
News Archive
Date
Category
Advertisement
News Category

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Cholesterol High Cholesterol Drug Toxicity Heart Attack Diet Lifestyle and Heart Disease Body Mass Index Signature Drug Toxicity Cholesterol - The Enigma Chemical Liposuction Heart Attack- Lifestyle Risks 

Most Popular on Medindia

Find a Hospital Find a Doctor Drug Interaction Checker Diaphragmatic Hernia Indian Medical Journals Noscaphene (Noscapine) Post-Nasal Drip Nutam (400mg) (Piracetam) Loram (2 mg) (Lorazepam) Accident and Trauma Care
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close
×

Pfizer's Best-selling Cholesterol Drug Lipitor Open for Generic Competition Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests